Literature DB >> 17311266

The effect of depression on quality of life of patients with type II diabetes mellitus.

Ibrahim Eren1, Ozlem Erdi, Mehmet Sahin.   

Abstract

Diabetes mellitus (DM) is a frequently encountered metabolic disease with chronic features and involves numerous complications throughout its course, which causes severe restriction and disability in an individual's life. It has been reported that the incidence of depression is higher in diabetic patients and that diabetes is one of the risk factors in the development of depression. It has also been reported that co-morbid psychiatric disorders cause further deterioration in the quality of life in diabetic patients. The aim of this study was to investigate the effects of depression on the quality of life in type II DM patients. Sixty patients (30 females and 30 males) with current major depressive episode diagnosed according to DSM-IV criteria, and 48 type II DM patients (30 females and 18 males) without a major depressive episode (non-depressed group) were included in the study. All patients were evaluated with a semi-structured interview form to assess the clinical features of DM, Hamilton Rating Scale for Anxiety (HRSA), Hamilton Rating Scale for Depression (HRSD), and the Turkish version of The World Health Organization Quality of Life Assessment-Brief (WHOQOL-BREF). The HRSD and HRSA scores in the depressed group were 24.87+/-4.83 and 21.07+/-5.44, respectively, whereas those in the non-depressed group were 7.83+/-3.92 and 6.88+/-3.43, respectively. The physical health, psychological health, social relationship, environmental and social pressure domain, general health-related quality of life, overall quality of life, and WHOQOL-BREF total scores were found significantly lower in the depressed group than the non-depressed group. There were significant negative correlations between HRSD and HRSA scores and physical health, psychological health, social relationship, environmental and social pressure domain, general health-related quality of life, overall quality of life, and WHOQOL-BREF total scores. Furthermore, there were significant negative correlations between the HbA1c level and physical health, social relationship, environmental domain, social pressure domain, general health-related quality of life, overall quality of life, and WHOQOL-BREF total scores. However, there was a significant positive correlation between the level of education and physical health, psychological health, social relationship, environmental social pressure domain, overall quality of life, and WHOQOL-BREF total scores. There were significant negative correlations between social relationship domain score, and age and duration of illness. Our study demonstrates that the presence of depression in type II DM further deteriorates the quality of life of the patients. Since treating depression would have a beneficial effect on the quality of life, clinicians should carefully assess for depression associated with type II DM. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17311266     DOI: 10.1002/da.20288

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  30 in total

Review 1.  Serious psychological distress and diabetes: a review of the literature.

Authors:  Leonard E Egede; Clara E Dismuke
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Depression and subjective quality of life among outpatients with diabetes mellitus at a teaching hospital in Nigeria.

Authors:  Bawo O James; Olufemi Morakinyo; George O Eze; Ambrose O Lawani; Joyce O Omoaregba
Journal:  Ment Health Fam Med       Date:  2010-09

3.  The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Authors:  Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva
Journal:  Qual Life Res       Date:  2019-02-07       Impact factor: 4.147

4.  The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes.

Authors:  Leonard E Egede; Charles Ellis
Journal:  Diabetes Technol Ther       Date:  2010-04       Impact factor: 6.118

5.  Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey.

Authors:  Calypse B Agborsangaya; Darren Lau; Markus Lahtinen; Tim Cooke; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2012-06-09       Impact factor: 4.147

6.  Alexithymia, more than depression, influences glycaemic control of type 2 diabetic patients.

Authors:  A Luca; M Luca; M Di Mauro; F Palermo; F Rampulla; C Calandra
Journal:  J Endocrinol Invest       Date:  2015-01-18       Impact factor: 4.256

Review 7.  The bidirectional relation between psychiatric disorders with selected cardiovascular and endocrinal diseases: an Egyptian perspective.

Authors:  Tarek Okasha; Ash-Shayma Radwan
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

8.  Depression treatment and health-related quality of life among adults with diabetes and depression.

Authors:  Ebtihag O Alenzi; Usha Sambamoorthi
Journal:  Qual Life Res       Date:  2015-11-21       Impact factor: 4.147

9.  Validation of WHOQOL-BREF in Malayalam and Determinants of Quality of Life Among People With Type 2 Diabetes in Kerala, India.

Authors:  Aswathy Sreedevi; Sandhya Cherkil; Deepak Soman Kuttikattu; Leelamoni Kamalamma; Brian Oldenburg
Journal:  Asia Pac J Public Health       Date:  2015-09-29       Impact factor: 1.399

Review 10.  Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium.

Authors:  Miranda T Schram; Caroline A Baan; François Pouwer
Journal:  Curr Diabetes Rev       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.